Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics

Developing one agent that has reasonable stability and ultrahigh photothermal conversion efficiency (PTCE) for near-infrared (NIR) photothermal cancer treatment remains a great challenge, but is highly desirable. In this research, we developed a perylene diimide (PDI)-based oligomer (OPDI) through c...

Full description

Saved in:
Bibliographic Details
Main Authors: Gong, Qiuyu, Xing, Jie, Huang, Yinjuan, Wu, Aiguo, Yu, Jing, Zhang, Qichun
Other Authors: School of Materials Science and Engineering
Format: Article
Language:English
Published: 2021
Subjects:
Online Access:https://hdl.handle.net/10356/148637
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-148637
record_format dspace
spelling sg-ntu-dr.10356-1486372023-07-14T16:01:17Z Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics Gong, Qiuyu Xing, Jie Huang, Yinjuan Wu, Aiguo Yu, Jing Zhang, Qichun School of Materials Science and Engineering Science::Chemistry::Biochemistry Colloids Rodent Models Developing one agent that has reasonable stability and ultrahigh photothermal conversion efficiency (PTCE) for near-infrared (NIR) photothermal cancer treatment remains a great challenge, but is highly desirable. In this research, we developed a perylene diimide (PDI)-based oligomer (OPDI) through coupling monomeric PDI derivatives together. OPDI exhibited slightly red-shifted absorption at NIR region compared with monomeric PDI. More importantly, the self-assembled OPDI nanoparticles not only exhibited high stability and preferable biocompatibility, but also possessed an ultrahigh PTCE (up to 79.8%, higher than many other photothermal agents reported before). This OPDI photothermal agent has been demonstrated to exhibit excellent therapeutic effects. Our research provides a guide for the exploitation of photothermal agents with ultrahigh PTCE. Ministry of Education (MOE) National Research Foundation (NRF) Accepted version 2021-05-17T08:32:31Z 2021-05-17T08:32:31Z 2020 Journal Article Gong, Q., Xing, J., Huang, Y., Wu, A., Yu, J. & Zhang, Q. (2020). Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics. ACS Applied Bio Materials, 3(3), 1607-1615. https://dx.doi.org/10.1021/acsabm.9b01187 2576-6422 https://hdl.handle.net/10356/148637 10.1021/acsabm.9b01187 3 3 1607 1615 en NRF-NRFF11-2019-0004 Grants RG 94/18 Grants RG 111/17, RG 2/17, RG 114/16, RG 113/18 Grants MOE 2017-T2-1-021 MOE 2018-T2-1- 070 ACS Applied Bio Materials This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Applied Bio Materials, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acsabm.9b01187 application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Chemistry::Biochemistry
Colloids
Rodent Models
spellingShingle Science::Chemistry::Biochemistry
Colloids
Rodent Models
Gong, Qiuyu
Xing, Jie
Huang, Yinjuan
Wu, Aiguo
Yu, Jing
Zhang, Qichun
Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics
description Developing one agent that has reasonable stability and ultrahigh photothermal conversion efficiency (PTCE) for near-infrared (NIR) photothermal cancer treatment remains a great challenge, but is highly desirable. In this research, we developed a perylene diimide (PDI)-based oligomer (OPDI) through coupling monomeric PDI derivatives together. OPDI exhibited slightly red-shifted absorption at NIR region compared with monomeric PDI. More importantly, the self-assembled OPDI nanoparticles not only exhibited high stability and preferable biocompatibility, but also possessed an ultrahigh PTCE (up to 79.8%, higher than many other photothermal agents reported before). This OPDI photothermal agent has been demonstrated to exhibit excellent therapeutic effects. Our research provides a guide for the exploitation of photothermal agents with ultrahigh PTCE.
author2 School of Materials Science and Engineering
author_facet School of Materials Science and Engineering
Gong, Qiuyu
Xing, Jie
Huang, Yinjuan
Wu, Aiguo
Yu, Jing
Zhang, Qichun
format Article
author Gong, Qiuyu
Xing, Jie
Huang, Yinjuan
Wu, Aiguo
Yu, Jing
Zhang, Qichun
author_sort Gong, Qiuyu
title Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics
title_short Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics
title_full Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics
title_fullStr Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics
title_full_unstemmed Perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics
title_sort perylene diimide oligomer nanoparticles with ultrahigh photothermal conversion efficiency for cancer theranostics
publishDate 2021
url https://hdl.handle.net/10356/148637
_version_ 1773551353276137472